Basit öğe kaydını göster

dc.contributor.authorDanel, F
dc.contributor.authorHall, LMC
dc.contributor.authorDuke, B
dc.contributor.authorGur, D
dc.contributor.authorLivermore, DM
dc.date.accessioned2019-12-12T06:25:39Z
dc.date.available2019-12-12T06:25:39Z
dc.date.issued1999
dc.identifier.issn0066-4804
dc.identifier.urihttps://doi.org/10.1128/AAC.43.6.1362
dc.identifier.urihttp://hdl.handle.net/11655/16308
dc.description.abstractPseudomonas aeruginosa isolates 871 and 873 were isolated at Hacettepe University Hospital in Ankara and were highly resistant to ceftazidime (MIC, 128 mu g/ml). Each produced three beta-lactamases, with pIs of 5.3, 6.1, and 7.9. The beta-lactamase with a pI of 5.3 was previously shown to be PER-1 enzyme, The antibiograms of the isolates were not entirely explained by production of PER-1 enzyme, insofar as ceftazidime resistance was incompletely reversed by clavulanate. The enzymes with pIs of 6.1 and 7.9 were therefore investigated. The enzyme with a pI of 6.1 proved to be a novel mutant of OXA-10, which we designated OXA-17, and had asparagine changed to serine at position 73 of the protein. When cloned into Escherichia coli XL1-blue, OXA-17 enzyme conferred greater resistance to cefotaxime, latamoxef, and cefepime than did OXA-10, but it had only a marginal (two- to fourfold) effect on the MIC of ceftazidime. This behavior contrasted with that of previous OXA-10 mutants, specifically OXA-11, -14, and -16, which predominately compromise ceftazidime. Extracted OXA-17 enzyme had relatively greater activity than OXA-10 against oxacillin, cloxacillin, and cefotaxime but, in terms of k(cat)/K-m, it had lower catalytic efficiency against most beta-lactams, The enzyme with a pI of 7.9 was shown by gene sequencing to be OXA-2.
dc.language.isoen
dc.publisherAmer Soc Microbiology
dc.relation.isversionof10.1128/AAC.43.6.1362
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMicrobiology
dc.subjectPharmacology & Pharmacy
dc.titleOxa-17, A Further Extended-Spectrum Variant Of Oxa-10 Beta-Lactamase, Isolated From Pseudomonas Aeruginosa
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalAntimicrobial Agents And Chemotherapy
dc.contributor.departmentTıbbi Mikrobiyoloji
dc.identifier.volume43
dc.identifier.issue6
dc.identifier.startpage1362
dc.identifier.endpage1366
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster